Academic Journal
Q3Future Medicinal Chemistry
About Future Medicinal Chemistry
Future Medicinal Chemistry is a scholarly journal published by Taylor and Francis Ltd.. SCImago 2025 lists it in Q3, with an SJR of 0.429 and H-index of 106.
Coverage: 2009-2026. Research categories: Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4).
Source-backed journal facts
Topics in published research
Computational Drug Discovery Methods; Synthesis and biological activity; Click Chemistry and Applications; Diverse Scientific and Economic Studies; Human auditory perception and evaluation; Cancer therapeutics and mechanisms.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Novel piperazine–pyridine conjugates as aldose reductase inhibitors: synthesis, DFT analysis, molecular docking, ADME evaluation, DPPH radical scavenging activity, and in vitro aldose reductase inhibitory activity
Saurabh Kumar Gupta, Amit Verma, Rakhi Mishra
2026-10-04 · DOI: 10.1080/17568919.2026.2739924New small molecular drug approvals for 2025: clinical applications, mechanism of action, and chemical synthesis
Han-Bo Seng, Yi-Ru Bai, Dan-Dan Shen, Chun-Li Wang et al.
2026-10-03 · DOI: 10.1080/17568919.2026.2741243The next generation of orthopoxvirus antivirals: preparing for future threats
Ajit D. Jagtap, Zhilong Yang, Zhengqiang Wang
2026-10-02 · DOI: 10.1080/17568919.2026.2741240Exploration of newly synthesized sulfonohydrazides as potential enzyme inhibitors: synthesis, characterization, and in silico studies
Lubabah Abdul Karim, Amara Mumtaz, Syeda Abida Ejaz, Tariq Ismail et al.
2026-10-01 · DOI: 10.1080/17568919.2026.2736313Chalcone-pyridine/pyrimidine hybrids: promising candidates for anticancer drug development
Junjian Wang, Lumei Dai, Shifang Wen, Chuangjun Liu et al.
2026-10-01 · DOI: 10.1080/17568919.2026.2741225Heterocyclic scaffolds targeting IDO1: progress in medicinal chemistry and clinical development
Ankush Kumar, Vishakha Sharma, Rajiv Patel, Rajwinder Kaur et al.
2026-09-30 · DOI: 10.1080/17568919.2026.2741229Emerging antifungal compounds and strategies targeting Candida species: a mini-review of advances from 2010 to 2025
Marta Kłos, Monika Janeczko, Bartosz Mickiewicz, Paweł Kozyra et al.
2026-09-30 · DOI: 10.1080/17568919.2026.2736311Gramicidin S analogues as a pathway to overcome antimicrobial resistance
Tatiana S. Shkuratova, Daria V. Andreeva, Alexander S. Tikhomirov, Andrey E. Shchekotikhin et al.
2026-09-25 · DOI: 10.1080/17568919.2026.2736285Rational design and synthesis of sulfonamide-substituted coumarinyl-imidazolone hybrids against multidrug-resistant microbial strains: computational and biological evaluation studies
Preetesh Kumar Panda, Sudhir Kumar Paidesetty, Alaka Sahoo, Aruna Ghose et al.
2026-09-24 · DOI: 10.1080/17568919.2026.2736295“Sustainable synthesis and biological evaluation of novel benzo[4,5]imidazo[1,2-a]pyrimidine carboxamide derivatives”
Bhaktiben R. Bhatt, Kamalkishor Pandey, Sagar Patel, Tarosh Patel et al.
2026-10-02 · DOI: 10.1080/17568919.2026.2732257Antifungal metallacarboranes modulate Hsp90 activity
Konrad Kubiński, Paweł Czubak, Aleksandra Martyna, Paweł Kozyra et al.
2026-10-02 · DOI: 10.1080/17568919.2026.2732258Recent advances in the therapeutic potential of quinoline-piperazine hybrids
Omkumar Prajapati, Om Sathavara, Unnati Barodia, Priya Sharma et al.
2026-10-02 · DOI: 10.1080/17568919.2026.2726192Design, synthesis, and computational assessment of bis ‑oxadiazole ligands targeting α-amylase and α-glucosidase: DFT, docking, and ADME studies
Shoaib Khan, Tayyiaba Iqbal, Bibi Nazia Murtaza, Jamoliddin Razzokov et al.
2026-10-02 · DOI: 10.1080/17568919.2026.2732262Exploring the antidiabetic potential of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids: synthesis, α-glucosidase inhibition and molecular modeling studies
Anshul Grover, Vivek Asati, Jayant Sindhu, Kashmiri Lal et al.
2026-10-02 · DOI: 10.1080/17568919.2026.2732256Indole hybrids as promising anti-hepatocellular carcinoma agents: a comprehensive review of recent advances and therapeutic prospects
Xiaoguang Jiang, Bentao Jia, Xiaotong Yang, Ling Qi et al.
2026-09-15 · DOI: 10.1080/17568919.2026.2732261Coumarin derivatives combating antibacterial resistance: molecular modeling-driven insights and comprehensive SAR elucidation targeting DNA gyrase and topoisomerase IV
Aanchal Khanna, Karanvir Singh, Alok Raj, Harshavardhan Gupta et al.
2026-09-11 · DOI: 10.1080/17568919.2026.2732259A call for applications of drug repurposing/secondary pharmaceutical combinations strategy
Israel Agranat, Ilaria D’Acquarica
2026-10-02 · DOI: 10.1080/17568919.2026.2732255Bis -thiosemicarbazone derivative as starting agent for synthesis of anti-breast cancer agents and targeting PIM-1 kinase
Alaa M. Abu Alnjaa, Jihan Qurban, Eman M. H. Abbas, Hossa F. Alshareef et al.
2026-09-17 · DOI: 10.1080/17568919.2026.2726193Organometallic compounds as antimicrobial agents: emerging chemical types, mechanistic insights and future directions
Gonzalo Scalese, Dinorah Gambino
2026-10-02 · DOI: 10.1080/17568919.2026.2726187Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents
Ahmed M. Metwaly, Hazem Elkady, Walid E. Elgammal, Ibrahim H. Eissa et al.
2026-10-02 · DOI: 10.1080/17568919.2026.2727415Reviews
Community Reviews
Version History
October 4, 2026 at 9:22 pm
October 2, 2026